Logo image of ARCAD.AS

ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

AMS:ARCAD - Euronext Amsterdam - NL0006237562 - Common Stock - Currency: EUR

41.22  -0.06 (-0.15%)

Fundamental Rating

5

ARCAD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 28 industry peers in the Professional Services industry. ARCAD has an excellent profitability rating, but there are some minor concerns on its financial health. ARCAD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ARCAD had positive earnings in the past year.
In the past year ARCAD had a positive cash flow from operations.
ARCAD had positive earnings in each of the past 5 years.
Each year in the past 5 years ARCAD had a positive operating cash flow.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

ARCAD's Return On Assets of 6.22% is fine compared to the rest of the industry. ARCAD outperforms 71.43% of its industry peers.
ARCAD has a better Return On Equity (19.71%) than 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.91%, ARCAD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ARCAD is in line with the industry average of 11.14%.
The 3 year average ROIC (9.74%) for ARCAD is below the current ROIC(11.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROIC 11.91%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of ARCAD (6.26%) is better than 75.00% of its industry peers.
ARCAD's Profit Margin has improved in the last couple of years.
ARCAD has a better Operating Margin (10.03%) than 71.43% of its industry peers.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.03%
PM (TTM) 6.26%
GM N/A
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ARCAD is creating value.
The number of shares outstanding for ARCAD has been reduced compared to 1 year ago.
The number of shares outstanding for ARCAD has been increased compared to 5 years ago.
Compared to 1 year ago, ARCAD has an improved debt to assets ratio.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.60 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARCAD's Altman-Z score of 2.60 is in line compared to the rest of the industry. ARCAD outperforms 53.57% of its industry peers.
The Debt to FCF ratio of ARCAD is 3.66, which is a good value as it means it would take ARCAD, 3.66 years of fcf income to pay off all of its debts.
ARCAD has a Debt to FCF ratio of 3.66. This is in the better half of the industry: ARCAD outperforms 64.29% of its industry peers.
ARCAD has a Debt/Equity ratio of 0.78. This is a neutral value indicating ARCAD is somewhat dependend on debt financing.
ARCAD has a Debt to Equity ratio (0.78) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Altman-Z 2.6
ROIC/WACC1.81
WACC6.57%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

ARCAD has a Current Ratio of 1.22. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD has a better Current ratio (1.22) than 64.29% of its industry peers.
ARCAD has a Quick Ratio of 1.22. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD has a Quick ratio of 1.22. This is in the better half of the industry: ARCAD outperforms 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.36% over the past year.
Looking at the last year, ARCAD shows a small growth in Revenue. The Revenue has grown by 3.20% in the last year.
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.98%
Revenue 1Y (TTM)3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.91%

3.2 Future

Based on estimates for the next years, ARCAD will show a decrease in Earnings Per Share. The EPS will decrease by -5.28% on average per year.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.77 indicates a quite expensive valuation of ARCAD.
Based on the Price/Earnings ratio, ARCAD is valued a bit cheaper than 60.71% of the companies in the same industry.
ARCAD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
ARCAD is valuated rather expensively with a Price/Forward Earnings ratio of 23.99.
The rest of the industry has a similar Price/Forward Earnings ratio as ARCAD.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, ARCAD is valued at the same level.
Industry RankSector Rank
PE 26.77
Fwd PE 23.99
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.29% of the companies in the same industry are more expensive than ARCAD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ARCAD is valued a bit cheaper than the industry average as 67.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.22
EV/EBITDA 8.35
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ARCAD may justify a higher PE ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)2.76
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

More info and screens

5

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
The stock price of ARCAD dropped by -25.19% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
ARCAD's Dividend Yield is a higher than the industry average which is at 3.24.
ARCAD's Dividend Yield is comparable with the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

On average, the dividend of ARCAD grows each year by 31.53%, which is quite nice.
Dividend Growth(5Y)31.53%
Div Incr Years5
Div Non Decr Years5
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

ARCAD pays out 31.28% of its income as dividend. This is a sustainable payout ratio.
DP31.28%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

More info and screens

ARCADIS NV

AMS:ARCAD (4/25/2025, 7:00:00 PM)

41.22

-0.06 (-0.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-07 2025-05-07
Inst Owners56.88%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap3.73B
Analysts82.22
Price Target73.38 (78.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.85
Dividend Growth(5Y)31.53%
DP31.28%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.43%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-4.39%
Revenue beat(4)0
Avg Revenue beat(4)-11.32%
Min Revenue beat(4)-30.71%
Max Revenue beat(4)-4.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.69%
PT rev (3m)-2.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.61%
EPS NY rev (3m)-6.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE 26.77
Fwd PE 23.99
P/S 0.96
P/FCF 12.22
P/OCF 10.65
P/B 3.02
P/tB N/A
EV/EBITDA 8.35
EPS(TTM)1.54
EY3.74%
EPS(NY)1.72
Fwd EY4.17%
FCF(TTM)3.37
FCFY8.18%
OCF(TTM)3.87
OCFY9.39%
SpS42.9
BVpS13.63
TBVpS-3.02
PEG (NY)2.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROCE 16.66%
ROIC 11.91%
ROICexc 14.06%
ROICexgc 58.82%
OM 10.03%
PM (TTM) 6.26%
GM N/A
FCFM 7.86%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ROICexc(3y)11.24%
ROICexc(5y)11.87%
ROICexgc(3y)46.91%
ROICexgc(5y)45.96%
ROCE(3y)13.66%
ROCE(5y)13.67%
ROICexcg growth 3Y8.93%
ROICexcg growth 5Y-10.74%
ROICexc growth 3Y2.55%
ROICexc growth 5Y6.48%
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Debt/EBITDA 1.82
Cap/Depr 32.14%
Cap/Sales 1.16%
Interest Coverage 7.48
Cash Conversion 66.16%
Profit Quality 125.51%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.6
F-Score8
WACC6.57%
ROIC/WACC1.81
Cap/Depr(3y)29.56%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.19%
Profit Quality(3y)159.52%
Profit Quality(5y)558.67%
High Growth Momentum
Growth
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.98%
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.91%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y42.73%
EBIT growth 3Y20.69%
EBIT growth 5Y17.72%
EBIT Next Year51.7%
EBIT Next 3Y21.55%
EBIT Next 5YN/A
FCF growth 1Y13.74%
FCF growth 3Y1.15%
FCF growth 5Y12.49%
OCF growth 1Y13.37%
OCF growth 3Y2.04%
OCF growth 5Y9.96%